Who we are

Bionevia was founded in 2007. Since the company's incorporation, we have developed a strong intellectual property position for our product portfolio and have assembled a strong management team of successful pharma executives. Our portfolio of products is poised to enter clinical trials for treatment of a range of conditions related to CNS and pain.

We are currently meeting with potential investors for our next round of financing and are looking forward to hearing from interested parties.

Our goal

We are working towards building a successful specialty pharmaceutical company which discovers, develops, and markets a portfolio of products addressing large and growing therapeutic markets, such as CNS and pain.